Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

Cited by (999)

Items 201–300 of 999

1. Increase in Carotid Artery Intima‐Media Thickness and Arterial Stiffness but Improvement in Several Markers of Endothelial Function after Initiation of Antiretroviral Therapy
   Marit G. A. van Vonderen, Elly A. M. Hassink, Michiel A. van Agtmael, Coen D.A. Stehouwer, Sven A. Danner, Peter Reiss, Yvo Michiel Smulders · 2009 · The Journal of Infectious Diseases
2. Stroke risk factors in an incident population in urban and rural Tanzania: a prospective, community-based, case-control study
   Richard William Walker, Ahmed Jusabani, Eric A. Aris, William K Gray, Nigel C. Unwin, Mark E. Swai, K. G. M. M. Alberti, Ferdinand M Mugusi · 2013 · The Lancet Global Health
3. Clinical update: adverse effects of antiretroviral therapy
   Alexandra Calmy, Bernard J. Hirschel, David A. Cooper, Andrew D Carr · 2007 · The Lancet
4. Risk of myocardial infarction among people living with HIV: an updated systematic review and meta-analysis
   Oghenowede Eyawo, Gwenyth Brockman, Charles H. Goldsmith, Mark Hull, Scott Alexander Lear, Matthew T. Bennett, Silvia A. Guillemi, Conrado Franco‐Villalobos, Ahmed Adam, Edward J. Mills et al. · 2019 · BMJ Open
5. Effects of Antiretroviral Therapy on Immune Function and Arterial Inflammation in Treatment-Naive Patients With Human Immunodeficiency Virus Infection
   Markella V. Zanni, Mabel P. Toribio, Gregory K. Robbins, Tricia H. Burdo, Michael T. Lu, Amorina Ishai, Meghan N. Feldpausch, Amanda Martin, Kathy Melbourne, Virginia A. Triant et al. · 2016 · JAMA Cardiology
6. Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral Therapy
   Mark Jacob Siedner, June‐Ho Kim, Ruth N. Sentongo, Prossy Bibangambah, Linda Hemphill, Virginia A. Triant, Jessica Elizabeth Haberer, Jeffrey N. Martin, Adrienne Rain Mocello, Yap Boum et al. · 2015 · The Journal of Infectious Diseases
7. Dyslipidemia and its Treatment in HIV Infection.
   Carl Grünfeld · 2010 · PubMed
8. Influence of Antiretroviral Therapy on Oxidative Stress and Cardiovascular Risk: A Prospective Cross-Sectional Study in HIV-Infected Patients
   Mar Masiá, Sergio Padilla, Enrique Bernal, María Almenar, Juan Molina, Ildefonso Hernández‐Aguado, Mafia L. Graells, Félix Gutiérrez · 2007 · Clinical Therapeutics
9. HIV Protease Inhibitors Disrupt Lipid Metabolism by Activating Endoplasmic Reticulum Stress and Inhibiting Autophagy Activity in Adipocytes
   Beth Shoshana Zha, Xiaoshan Wan, Xiaoxuan Zhang, Weibin Zha, Jun Liang Zhou, Martin Wabitsch, Guangji Wang, Vijay Lyall, Phillip B. Hylemon, Huiping Zhou · 2013 · PLoS ONE
10. Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial
    Vincent Soriano, Pilar García‐Gascó, Eugenia Vispo, Andrés Ruiz-Sancho, F. Blanco, Luz Martín‐Carbonero, Sonia Rodríguez‐Nóvoa, Judit Morelló, Carmen de Mendoza, P. Rivas et al. · 2007 · Journal of Antimicrobial Chemotherapy
11. Immune Activation and Collateral Damage in AIDS Pathogenesis
    Frank F. Miedema, Mette D. Hazenberg, Kiki Tesselaar, Debbie van Baarle, Rob J. de Boer, José A. M. Borghans · 2013 · Frontiers in Immunology
12. Endothelial dysfunction, increased inflammation, and activated coagulation in HIV ‐infected patients improve after initiation of highly active antiretroviral therapy
    Hanne Arildsen, KE Sørensen, JM Ingerslev, Lars Jørgen Østergaard, Alex Lund Laursen · 2012 · HIV Medicine
13. Association of antiretroviral therapy with fibrinogen levels in HIV-infection
    Erin Madden, Grace Lee, Donald P. Kotler, CHRISTINE A. WANKE, Cora Elizabeth Lewis, Russell P. Tracy, Steven B. Heymsfield, Michael G. Shlipak, Peter Bacchetti, Rebecca Scherzer et al. · 2008 · AIDS
14. MECHANISMS IN ENDOCRINOLOGY: Metabolic and body composition effects of newer antiretrovirals in HIV-infected patients
    Suman Srinivasa, Steven Kyle Grinspoon · 2014 · European Journal of Endocrinology
15. HIV therapy, metabolic syndrome, and cardiovascular risk
    Vivian Y Pao, Grace A. Lee, Carl Grünfeld · 2008 · Current Atherosclerosis Reports
16. Accelerated aging and human immunodeficiency virus infection: Emerging challenges of growing older in the era of successful antiretroviral therapy
    Ramona Bhatia, Patrick Ryscavage, Babafemi Taiwo · 2011 · Journal of NeuroVirology
17. HIV Tat Induces Expression of ICAM-1 in HUVECs: Implications for miR-221/-222 in HIV-Associated Cardiomyopathy
    Ming Duan, Honghong Yao, Guoku Hu, Xian‐Ming Chen, Amie K. Lund, Shilpa J. Buch · 2013 · PLoS ONE
18. Association Between Human Immunodeficiency Virus Infection and Stiffness of the Common Carotid Artery
    Eric C. Seaberg, Lorie Benning, A. Richey Sharrett, Jason Lazar, Howard Neil Hodis, Wendy Jean Mack, Mark Jacob Siedner, John Phair, Lawrence Kingsley, Robert C. Kaplan · 2010 · Stroke
19. Progression of Carotid Intima-Media Thickness in a Contemporary Human Immunodeficiency Virus Cohort
    Jeffrey V. Baker, W. Keith Henry, P. Patel, Timothy J. Bush, Lois J. Conley, Wendy Jean Mack, Edgar Turner Overton, Matthew Jay Budoff, John Hammer, Charles C. J. Carpenter et al. · 2011 · Clinical Infectious Diseases
20. Endothelial and platelet function alterations in HIV-infected patients
    Paolo Gresele, Emanuela Falcinelli, Manuela Sebastiano, Franco Baldelli · 2011 · Thrombosis Research
21. Trends in Cardiovascular Disease Mortality Among Persons With HIV in New York City, 2001–2012
    David B. Hanna, Chitra Ramaswamy, Robert C. Kaplan, Jorge R. Kizer, Kathryn Anastos, Demetre Daskalakis, Regina Zimmerman, Sarah Braunstein · 2016 · Clinical Infectious Diseases
22. Cardiovascular implications from untreated human immunodeficiency virus infection
    Jeffrey V. Baker, Jens Dilling Lundgren · 2011 · European Heart Journal
23. Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy
    Leonardo Calza, Roberto Manfredi, Daria Pocaterra, Francesco Chiodo · 2008 · Journal of Infection
24. Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive Persons
    Margalida Rotger, Tracy R. Glass, Thomas Junier, Jens Dilling Lundgren, James D. Neaton, Estella S. Poloni, Angélique B. van ’t Wout, Rubin Lubomirov, Sara Francesca Colombo, Raquel Martínez et al. · 2013 · Clinical Infectious Diseases
25. Types of Myocardial Infarction Among Human Immunodeficiency Virus–Infected Individuals in the United States
    Heidi M. Crane, Pathmaja Paramsothy, Daniel R. Drozd, Robin M. Nance, Joseph A. Delaney, Susan R. Heckbert, Matthew Jay Budoff, Greer Burkholder, James H. Willig, Michael J. Mugavero et al. · 2017 · JAMA Cardiology
26. Incidence of diabetes mellitus in a population‐based cohort of HIV‐infected and non‐HIV‐infected persons: the impact of clinical and therapeutic factors over time
    Tripathi, A., Liese, A. D., Jerrell, J. M., Zhang, J., Rizvi, A. A., Albrecht, H., Duffus, W. A. · 2014 · Diabetic Medicine
27. Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV‐Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial
    Jason V. Baker, Shweta Sharma, Amit C. Achhra, José Ignacio Bernardino, Johannes Richard Bogner, Daniel A. Duprez, Sean Emery, Brian Gazzard, Jonathan S. Gordin, Greg Grandits et al. · 2017 · Journal of the American Heart Association
28. T-Cell Phenotypes, Apoptosis and Inflammation in HIV+ Patients on Virologically Effective cART with Early Atherosclerosis
    Esther Merlini, Kety Luzi, Elisa Suardi, Alessandra Barassi, Maddalena Cerrone, Javier Sánchez‐Martínez, Francesca Bai, G.V. Melzi d’Eril, Antonella d’Arminio Monforte, Giulia Carla Marchetti · 2012 · PLoS ONE
29. Non-AIDS comorbidity burden differs by sex, race, and insurance type in aging adults in HIV care
    Frank Joseph Palella, Rachel L. D. Hart, Carl Armon, Ellen Tedaldi, Bienvenido G. Yangco, Richard Novák, Linda A. Battalora, Douglas J. Ward, Jun Li, Kate A. Buchacz · 2019 · AIDS
30. Antiretroviral Medications: Adverse Effects on the Kidney
    Jennifer K. Jao, Christina M. Wyatt · 2009 · Advances in Chronic Kidney Disease
31. Vitamin D deficiency in HIV infection: an underestimated and undertreated epidemic.
    Marilia Rita Pinzone, Michelino Di Rosa, Mariano Malaguarnera, Giordano Madeddu, Emanuele Focà, Giancarlo Ceccarelli, Gabriella d’Ettorre, Vullo, Rossella Fisichella, Bruno Santi Cacopardo et al. · 2013 · PubMed
32. Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents
    The RESPOND Study Group∗ · 2021 · AIDS
33. Consensus Review of the Treatment of Cardiovascular Disease in People With Hemophilia A and B
    Victor A. Ferraris, Leonard I. Boral, Alice Joy Cohen, Susan S. Smyth, Gilbert White · 2014 · Cardiology in Review
34. Metabolic syndrome among HIV-infected Taiwanese patients in the era of highly active antiretroviral therapy: prevalence and associated factors
    Pei‐Ying Wu, Chien‐Ching Hung, Wen‐Chun Liu, Chia-Yin Hsieh, Hsin‐Yun Sun, Ching-Lan Lu, Hsiu Wu, Kuo‐Liong Chien · 2012 · Journal of Antimicrobial Chemotherapy
35. HIV as a chronic disease
    Tabitha W. Mahungu, Alison Rodger, Margaret A. Johnson · 2009 · Clinical Medicine
36. Role of inflammation in HIV-1 disease progression and prognosis
    Hayley Ipp, Annalise E. Zemlin, Rajiv Timothy Erasmus, Richard Helmuth Glashoff · 2014 · Critical Reviews in Clinical Laboratory Sciences
37. Secondary dyslipidemia: its treatments and association with atherosclerosis
    Hidekatsu Yanai, Hiroshi Yoshida · 2020 · Global Health & Medicine
38. Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat
    Ruxandra-Cristina Marin, Tapan Behl, Nicoleta Negruţ, SIMONA GABRIELA BUNGAU · 2021 · Biomedicines
39. No Impairment of Endothelial Function or Insulin Sensitivity with 4 Weeks of the HIV Protease Inhibitors Atazanavir or Lopinavir‐Ritonavir in Healthy Subjects without HIV Infection: A Placebo‐Controlled Trial
    Michael P. Dubé, Changyu Shen, Martha Greenwald, Kieren J. Mather · 2008 · Clinical Infectious Diseases
40. HIV Infection and Carotid Artery Intima-media Thickness: Pooled Analyses Across 5 Cohorts of the NHLBI HIV-CVD Collaborative
    David B. Hanna, Mengye Guo, Petra Bůžková, Tracie L. Miller, Wendy S. Post, James H. Stein, Judith S. Currier, Richard A. Kronmal, Matthew S. Freiberg, Siiri Bennett et al. · 2016 · Clinical Infectious Diseases
41. Impact of Protease Inhibitor–Based Anti-Retroviral Therapy on Outcomes for HIV+ Kidney Transplant Recipients
    Deirdre L. Sawinski, B.A. Shelton, Shikha G. Mehta, R.D. Reed, Paul A. MacLennan, Sally K. Gustafson, Dorry Lidor Segev, Jayme E. Locke · 2017 · American Journal of Transplantation
42. The effect of initiation of antiretroviral therapy on monocyte, endothelial and platelet function in HIV ‐1 infection
    Jane A. O’Halloran, Eimear Dunne, MMP Gurwith, John Shearer Lambert, G Sheehan, Eoin R. Feeney, Anton Pozniak, Peter Reiss, Dermot J. Kenny, Patrick W. G. Mallon · 2015 · HIV Medicine
43. Biomarkers and HIV-associated cardiovascular disease
    Jason V. Baker, Daniel A. Duprez · 2010 · Current Opinion in HIV and AIDS
44. Recent Insights Into Cardiovascular Disease (CVD) Risk Among HIV-Infected Adults
    Robert C. Kaplan, David B. Hanna, Jorge R. Kizer · 2016 · Current HIV/AIDS Reports
45. HIV protease inhibitors and onset of cardiovascular diseases: A central role for oxidative stress and dysregulation of the ubiquitin–proteasome system
    Kathleen M. S. E. Reyskens, M. Faadiel Essop · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
46. Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects
    Giovanni Guaraldi, Chiara Stentarelli, Stefano Zona, Gabriella Orlando, Federica Carli, Guido Ligabue, Antonella Lattanzi, Giacomo Zaccherini, Rosario Rossi, Maria Grazia Modena et al. · 2009 · Atherosclerosis
47. Prevalence of cardiovascular diseases in HIV-infected outpatients: results from a prospective, multicenter cohort study
    Stefan Eßer, Götz Gelbrich, Norbert Hermann Brockmeyer, Alexander Goehler, Dirk Schadendorf, Raimund Erbel, Till Neumann, Nico Reinsch · 2012 · Clinical Research in Cardiology
48. Safety and Tolerability of Varenicline Tartrate (Champix ® /Chantix ® ) for Smoking Cessation in HIV-Infected Subjects: A Pilot Open-Label Study
    Qu Cui, Linda L. Robinson, Dawn Elston, Fiona Smaill, Jeffrey Cohen, Corinna Quan, Nancy McFarland, Lehana Thabane, Andrew McIvor, Johannes G. Zeidler et al. · 2011 · AIDS Patient Care and STDs
49. HIV-associated vascular diseases: Structural and functional changes, clinical implications
    Jean-Jacques Monsuez, Jean‐Christophe Charniot, L. Escaut, Elina Teicher, Benjamin Wyplosz, C. Couzigou, Noëlle Vignat, Daniel Vittecoq · 2009 · International Journal of Cardiology
50. Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART
    Pedro Enrique Cahn, O. H. M. Leite, A Rosales, Robinson L. Cabello, Carlos Álvarez, Carlos Seas, C Carcamo, Nancy Cure-Bolt, Gilber L'Italien, P Mantilla et al. · 2010 · The Brazilian Journal of Infectious Diseases
51. Risk of Cardiovascular Disease in an Aging HIV Population: Where Are We Now?
    Raquel Martín-Iguacel, Josep Maria Llibre, Nina Friis‐Møller · 2015 · Current HIV/AIDS Reports
52. Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South African HIV-Infected Patients
    Joel Alex Dave, Naomi Sharlene Levitt, Ian Louis Ross, Miguel Lacerda, Gary Maartens, Dirk Jacobus Blom · 2016 · PLoS ONE
53. Investigation of the levels of oxidative stress parameters in HIV and HIV-TB co-infected patients
    Olufunsho Awodele, S O Olayemi, Joseph A Nwite, Titilope Adenike Adeyemo · 2011 · The Journal of Infection in Developing Countries
54. Drug interactions between antineoplastic and antiretroviral therapies: Implications and management for clinical practice
    Nicolas Mounier, Christine Katlama, Dominique G. Costagliola, R M Chichmanian, Jean‐Philippe Spano · 2008 · Critical Reviews in Oncology/Hematology
55. Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution
    Jeroen P. H. van Wijk, Manuel Castro Cabezas · 2011 · International Journal of Vascular Medicine
56. Emerging clinical concerns in the ageing haemophilia patient
    Barbara A. Konkle, Craig M. Kessler, Louis M. Aledort, J. ANDERSEN, Patrick F. Fogarty, Peter A. Kouides, Doris V. K. Quon, Margaret V. Ragni, Anaadriana Zakarija, Bruce M. Ewenstein · 2009 · Haemophilia
57. Traditional Risk Factors Are More Relevant than HIV-Specific Ones for Carotid Intima-Media Thickness (cIMT) in a Brazilian Cohort of HIV-Infected Patients
    Antônio Guilherme Pacheco, Beatriz Gilda Jegerhorn Grinsztejn, Maria de Jesus Mendes da Fonseca, Ronaldo Ismerio Moreira, Valdilea Gonçalves Veloso, Ruth Khalili Friedman, Marília Santini-Oliveira, Sandra Wagner Cardoso, Melissa Falcão, José Geraldo Mill et al. · 2015 · PLoS ONE
58. Low Nadir CD4 Cell Count Predicts Sustained Hypertension in HIV‐Infected Individuals
    Ingjerd Wangensteen Manner, Marius Trøseid, Olav Oektedalen, Morten Bækken, Ingrid Os · 2012 · Journal of Clinical Hypertension
59. Matrix metalloproteinase dysregulation in HIV infection: implications for therapeutic strategies
    Claudio Maria Mastroianni, Grazia Maria Liuzzi · 2007 · Trends in Molecular Medicine
60. ASHP Guidelines on Pharmacist Involvement in HIV Care
    Jason J. Schafer, Taylor K. Gill, Elizabeth M Sherman, Ian R. McNicholl, Bruce Hawkins · 2016 · American Journal of Health-System Pharmacy
61. Aging, Health, and Quality of Life for Older People Living With HIV in Sub-Saharan Africa: A Review and Proposed Conceptual Framework
    Mark Jacob Siedner · 2017 · Journal of Aging and Health
62. Magnitude and associated factors of diabetes mellitus and hypertension among adult HIV-positive individuals receiving highly active antiretroviral therapy at Jugal Hospital, Harar, Ethiopia
    Zerihun Ataro, Wondimye Ashenafi, J Fayera, Tekabe Abdosh · 2018 · HIV/AIDS - Research and Palliative Care
63. Persistent low-Level viremia in persons living with HIV undertreatment: An unresolved status
    Celia Crespo‐Bermejo, Eva Ramírez de Arellano, Violeta Lara‐Aguilar, Daniel Valle‐Millares, Marı́a Luisa Gómez-Lus, Ricardo Madrid, Luz Martín‐Carbonero, Verónica Briz · 2021 · Virulence
64. Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV ‐infected children
    TL Miller, William Borkowsky, Linda Anne DiMeglio, Laurie B. Dooley, Mitchell E. Geffner, Rohan Hazra, EJ McFarland, Armando J. Mendez, Kunjal Patel, George Kelly Siberry et al. · 2011 · HIV Medicine
65. A Randomized Comparative Trial of Continued Zidovudine/Lamivudine or Replacement With Tenofovir Disoproxil Fumarate/Emtricitabine in Efavirenz-Treated HIV-1-Infected Individuals
    Martin Fisher, Graeme J Moyle, Mohsen Shahmanesh, Chloe M. Orkin, Margaret Kingston, Edmund Wilkins, Jacqueline Ewan, Hui Liu, Ramin Ebrahimi, Geraldine Reilly · 2009 · JAIDS Journal of Acquired Immune Deficiency Syndromes
66. Markers of atherosclerosis and inflammation and mortality in patients with HIV infection
    Alexandra Mangili, Joseph F. Polak, Lien Quach, Jül Gerrior, CHRISTINE A. WANKE · 2010 · Atherosclerosis
67. Cardiovascular implications of HIV-induced dyslipidemia
    Chiara Giannarelli, Robert S. Klein, Juan J. Badimón · 2011 · Atherosclerosis
68. Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection
    K Samaras · 2007 · Journal of Antimicrobial Chemotherapy
69. Dropout from physical activity interventions in people living with HIV: a systematic review and meta-analysis
    Davy Vancampfort, James Mugisha, Justin A. Richards, M.A.F. De Hert, Alexandre Ramos Lazzarotto, Felipe Barreto Schuch, Michel Probst, Brendon Stubbs · 2016 · AIDS Care
70. Role of T‐Cell Dysfunction, Inflammation, and Coagulation in Microvascular Disease in HIV
    Arjun Sinha, Yifei Ma, Rebecca Scherzer, Sophia Hur, Danny Li, Peter Ganz, Steven G. Deeks, Priscilla Y. Hsue · 2016 · Journal of the American Heart Association
71. ACCF/AHA/ACP 2009 Competence and Training Statement: A Curriculum on Prevention of Cardiovascular Disease
    C. Noel Bairey Merz, Mark J. Alberts, Gary John Balady, Christie Mitchell Ballantyne, Kathy A. Berra, Henry R. Black, Roger Scott Blumenthal, Michael H. Davidson, Sara B. Fazio, Keith C. Ferdinand et al. · 2009 · Circulation
72. The Biology of Atherosclerosis: General Paradigms and Distinct Pathogenic Mechanisms Among HIV-Infected Patients
    Janet Lo, Jorge Plutzky · 2012 · The Journal of Infectious Diseases
73. Prevalence and prognostic significance of ECG abnormalities in HIV–infected patients: results from the Strategies for Management of Antiretroviral Therapy study
    Elsayed Z. Soliman, Ronald J. Prineas, Mollie Poehlman Roediger, Daniel A. Duprez, Franck Boccara, Christoph Boesecke, Christoph Stephan, Sally Hodder, James H. Stein, Jens Dilling Lundgren et al. · 2010 · Journal of Electrocardiology
74. Metabolic syndrome associated with HIV and highly active antiretroviral therapy
    Giuseppe Bárbaro, Gialuca Iacobellis · 2009 · Current Diabetes Reports
75. A new era of antiretroviral drug toxicity
    Alexandra Calmy, Bernard J. Hirschel, David A. Cooper, Andrew D Carr · 2008 · Antiviral Therapy
76. Associations between immune depression and cardiovascular events in HIV infection
    Caroline Anne Sabin, Lene Ryom, Stéphane De Wit, Amanda Mocroft, Andrew N. Phillips, Signe Westring Worm, Rainer K. Weber, Antonella d’Arminio Monforte, Peter Reiss, David A Kamara et al. · 2013 · AIDS
77. Lipid Levels and Changes in Body Fat Distribution in Treatment-Naive, HIV-1–Infected Adults Treated With Rilpivirine or Efavirenz for 96 Weeks in the ECHO and THRIVE Trials
    Pablo Tebas, Michael Sension, José Ramón Arribas, Dan Duiculescu, Éric Florence, Chien‐Ching Hung, Timothy J. Wilkin, Simon Vanveggel, Marita Stevens, Henri Deckx et al. · 2014 · Clinical Infectious Diseases
78. HIV protease inhibitors activate the adipocyte renin angiotensin system
    Franck Boccara, Martine Auclair, Ariel A. Cohen, Chloé Lefevre, Matthieu Prot, Jean‐Philippe Bastard, Jacqueline Capeau, Martine Caron · 2009 · Antiviral Therapy
79. The ageing of HIV: implications for geriatric medicine
    Fiona C. Kearney, A. R. Moore, Ciaran F. Donegan, John Shearer Lambert · 2010 · Age and Ageing
80. Increase in Non-AIDS Related Conditions as Causes of Death among HIV-Infected Individuals in the HAART Era in Brazil
    Antônio Guilherme Pacheco, Suely Hiromi Tuboi, José Cláudio Faulhaber, Lee H. Harrison, Mauro Schechter · 2008 · PLoS ONE
81. Sexual Orientation Differences in Modifiable Risk Factors for Cardiovascular Disease and Cardiovascular Disease Diagnoses in Men
    Billy A. Caceres, Abraham Aizer Brody, Perry N. Halkitis, Caroline G. Dorsen, Gary Yu, Deborah Ann Chyun · 2018 · LGBT Health
82. Mechanisms of Cardiovascular Disease in the Setting of HIV Infection
    Priscilla Y. Hsue · 2018 · Canadian Journal of Cardiology
83. Changes in oxidized lipids drive the improvement in monocyte activation and vascular disease after statin therapy in HIV
    Corrilynn O. Hileman, Randi L. Turner, Nicholas Funderburg, Richard D. Semba, Grace A. McComsey · 2015 · AIDS
84. Changes Over Time in Risk Factors for Cardiovascular Disease and Use of Lipid‐Lowering Drugs in HIV‐Infected Individuals and Impact on Myocardial Infarction
    Data Collection on Adverse Events of Anti‐HIV Drugs Study Group · 2008 · Clinical Infectious Diseases
85. Metabolic and Immune Activation Effects of Treatment Interruption in Chronic HIV-1 Infection: Implications for Cardiovascular Risk
    Pablo Tebas, Keith Henry, Roy M. Matining, Deborah Weng Cherng, John L. Schmitz, Hernan Valdez, Nasreen C. Jahed, Laurie Myers, William G. Powderly, David Allan Katzenstein · 2008 · PLoS ONE
86. Human Immunodeficiency Virus and Highly Active Antiretroviral Therapy–Associated Metabolic Disorders and Risk Factors for Cardiovascular Disease
    Erdembileg Anuurad, Alison M. Semrad, Lars Berglund · 2009 · Metabolic Syndrome and Related Disorders
87. The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: a meta-analysis of randomized trials
    Sheth, Siddharth H, Larson, Robin J · 2010 · BMC Infectious Diseases
88. Proinflammatory Markers, Insulin Sensitivity, and Cardiometabolic Risk Factors in Treated HIV Infection
    Katherine Samaras, Seng Khee Gan, Philip W. Peake, Andrew D Carr, Lesley V. Campbell · 2008 · Obesity
89. Cardiac effects in perinatally HIV‐infected and HIV‐exposed but uninfected children and adolescents: a view from the United States of America
    Steven E. Lipshultz, Tracie L. Miller, James D. Wilkinson, Gwendolyn B. Scott, Gabriel A. Somarriba, Thomas R. Cochran, Stacy D. Fisher · 2013 · Journal of the International AIDS Society
90. Epicardial adipose tissue is an independent marker of cardiovascular risk in HIV-infected patients
    Giovanni Guaraldi, Riccardo Scaglioni, Stefano Zona, Gabriella Orlando, Federica Carli, Guido Ligabue, Giulia Besutti, Pietro Bagni, Rosario Rossi, Maria Grazia Modena et al. · 2011 · AIDS
91. Temporal Changes in Causes of Death Among HIV-Infected Patients in the HAART Era in Rio de Janeiro, Brazil
    Antônio Guilherme Pacheco, Suely Hiromi Tuboi, Silvia Beatriz May, Luiz F S Moreira, Luciana Ramadas, Estêvão Portela Nunes, Mônica Merçon, José Cláudio Faulhaber, Lee H. Harrison, Mauro Schechter · 2009 · JAIDS Journal of Acquired Immune Deficiency Syndromes
92. Management of Stable Ischemic Heart Disease: Summary of a Clinical Practice Guideline From the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons
    Amir Qaseem, Stephan D. Fihn, Paul Dallas, Sankey Williams, Douglas K Owens, Paul Shekelle · 2012 · Annals of Internal Medicine
93. Effects of First-Line Use of Nucleoside Analogues, Efavirenz, and Ritonavir-Boosted Protease Inhibitors on Lipid Levels
    Andrew Martin Hill, Will Sawyer, Brian Gazzard · 2009 · HIV Clinical Trials
94. Prevalence of Cardiac Diastolic Dysfunction in HIV-Infected Patients: Results of the HIV-HEART Study
    Nico Reinsch, Kathrin Neuhaus, Stefan Eßer, Anja Potthoff, Martin Hower, Norbert Hermann Brockmeyer, Raimund M. Erbel, Till Neumann, The German Competence Network Heart Failure and the German Competence Network for HIV AIDS · 2010 · HIV Clinical Trials
95. Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients
    Mar Masiá, Sergio Padilla, Débora Álvarez-del Arco, Juan Carlos López, Ignacio de los Santos, Vincent Soriano, José Hernández‐Quero, Jesús Santos, Cristina Tural, Julia del Amo et al. · 2012 · AIDS
96. The Study to Understand the Natural History of HIV and AIDS in the Era of Effective Therapy (SUN Study)
    Claudia J. Vellozzi, J. T. Brooks, Timothy J. Bush, Lois J. Conley, Keith Henry, Charles C. J. Carpenter, Edgar Turner Overton, John Hammer, Kathleen C. Wood, Scott D. Holmberg et al. · 2008 · American Journal of Epidemiology
97. Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy
    Duale Ahmed, David Roy, Edana Cassol · 2018 · Mediators of Inflammation
98. Rate of Comorbidities Not Related to HIV Infection or AIDS among HIV‐Infected Patients, by CD4 Cell Count and HAART Use Status
    Richard D. Moore, Kelly A. Gebo, Gregory M. Lucas, Jeanne C. Keruly · 2008 · Clinical Infectious Diseases
99. Reduction in circulating markers of endothelial dysfunction in HIV‐infected patients during antiretroviral therapy
    Ulrik Sloth Kristoffersen, Klaus Fuglsang Kofoed, Gitte Kronborg, Ann-Kristine Weber Giger, Andreas Kjær, Anne‐Mette Lebech · 2009 · HIV Medicine
100. The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case–control study
     Andrea De Luca, Katleen de Gaetano Donati, Manuela Colafigli, Alessandro Cozzi‐Lepri, Amalia De Curtis, Andrea Gori, Laura Sighinolfi, Andrea Giacometti, Maria Rosaria Capobianchi, Alessandro D’Avino et al. · 2013 · BMC Infectious Diseases